ALLMedicine™ Aphthous Ulcers Center

Aug 6th, 2022 - Nonsexually acquired genital ulcers have been described among girls who are prepubertal after various viral illnesses due to mucosal inflammation from an immunologic response. Until recently, nonsexually acquired genital ulcers have only been asso...

Jun 9th, 2022 - The combination of diclofenac and propolis could enhance the healing of recurrent aphthous ulcers, instantly relieve symptoms, improve the quality of life, and present a de novo and cost-effective regime help in oral ulcer treatment. This study ai...

Apr 8th, 2022 - Hyperimmunoglobulinaemia D syndrome (HIDS) is a rare autosomal recessive disorder caused by mutations in the mevalonate kinase (MVK) gene, located on chromosome 12. The most common mutation identified in MVK gene so far is V377I. Compound heterozy...

Mar 31st, 2022 - Eligible study subjects will be randomized into two groups 8-18 weeks after surgery. One group will be maintained on tacrolimus according to the standard of care at our center. In the second group tacrolimus will be converted to sirolimus, with on...

Mar 25th, 2022 - Lesions commonly associated with HIV infection include oral candidiasis, herpes simplex infection, oral Kaposi's sarcoma, hairy leukoplakia, periodontal diseases (linear gingival erythema and necrotizing ulcerative periodontitis), xerostomia, huma...

Mar 17th, 2022 - Background: Vulvar aphthous ulcers have been described since the early 1900s. These non-sexually acquired genital ulcers typically appear in the perimenarchal population as 1-3 painful ulcers that spontaneously resolve within 21 days. Etiology is ...

Jun 9th, 2022 - The combination of diclofenac and propolis could enhance the healing of recurrent aphthous ulcers, instantly relieve symptoms, improve the quality of life, and present a de novo and cost-effective regime help in oral ulcer treatment. This study ai...

Mar 31st, 2022 - Eligible study subjects will be randomized into two groups 8-18 weeks after surgery. One group will be maintained on tacrolimus according to the standard of care at our center. In the second group tacrolimus will be converted to sirolimus, with on...

Mar 17th, 2022 - Background: Vulvar aphthous ulcers have been described since the early 1900s. These non-sexually acquired genital ulcers typically appear in the perimenarchal population as 1-3 painful ulcers that spontaneously resolve within 21 days. Etiology is ...

Nov 4th, 2021 - Aphthous ulcers of the mouth or esophagus can interfere with eating, resulting in malnutrition and wasting. Thalidomide has been proposed as an effective therapy for severe forms of aphthous ulceration in AIDS patients. Patients are randomized to ...

Sep 2nd, 2021 - Background: oral ulceration is the earliest and commonest manifestation of Behcet's disease (BD). Minor aphthous like ulcers (<10 mm in diameter) are the most common type (85%); major or herpetiform ulcers are less frequent. It is occurred about i...

Mar 17th, 2022 - Background: Vulvar aphthous ulcers have been described since the early 1900s. These non-sexually acquired genital ulcers typically appear in the perimenarchal population as 1-3 painful ulcers that spontaneously resolve within 21 days. Etiology is ...

Apr 2nd, 2021 - Transcript:Adam M. Brufsky, MD: Right. So the last thing we’ll talk about in terms of these targeted therapies is we have one that’s already been approved. Where does it fit in now, I guess it’s the old school one, this is old school which is ever...

Mar 30th, 2021 - The European Commission (EC) has granted marketing clearance for risdiplam (Evrysdi, PTC Therapeutics), the first oral treatment for patients with certain types of spinal muscular atrophy (SMA). Risdiplam is indicated for the treatment of 5q SMA i...

Mar 1st, 2021 - The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization for risdiplam (Evrysdi), the first treatment that can be given orally to patients with certain types of spinal...

Jun 22nd, 2020 - Apremilast was highly effective in treating patients with severe recurrent aphthous stomatitis, with rapid response and an excellent safety profile, results from a small pilot study showed. Dr.